S

Sjoukje J. C. van der Stegen

Chan Zuckerberg Initiative (United States)

ORCID: 0000-0002-3839-3124

Publishes on CAR-T cell therapy research, Immune Cell Function and Interaction, T-cell and B-cell Immunology. 26 papers and 6.5k citations.

26Publications

6.5kTotal Citations

CAR-T cell therapy research Immune Cell Function and Interaction T-cell and B-cell Immunology Viral Infectious Diseases and Gene Expression in Insects Immunotherapy and Immune Responses

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

Justin Eyquem, Jorge Mansilla‐Soto, Theodoros Giavridis et al.|Nature|2017

Cited by 1.8kOpen Access

CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade

Theodoros Giavridis, Sjoukje J. C. van der Stegen, Justin Eyquem et al.|Nature Medicine|2018

Cited by 1.2kOpen Access

Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells

Zeguo Zhao, Maud Condomines, Sjoukje J. C. van der Stegen et al.|Cancer Cell|2015

Cited by 832Open Access

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

Mohamad Hamieh, Anton Dobrin, Annalisa Cabriolu et al.|Nature|2019

Cited by 648Open Access

The pharmacology of second-generation chimeric antigen receptors

Sjoukje J. C. van der Stegen, Mohamad Hamieh, Michel Sadelain|Nature Reviews Drug Discovery|2015

Cited by 545Open Access